Recursion Pharmaceuticals...

NASDAQ: RXRX · Real-Time Price · USD
5.77
0.13 (2.30%)
At close: Aug 15, 2025, 3:59 PM
5.77
0.00%
After-hours: Aug 15, 2025, 07:58 PM EDT

Recursion Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-171.9M -202.49M -178.91M -95.84M -97.54M -91.37M -93M -93.02M -76.73M -65.33M -57.49M -60.45M -65.56M -55.98M -64.93M -47.43M -43.4M -30.72M
Depreciation & Amortization
23.85M 19.33M 12.95M 7.2M 8M 7.4M 15.62M 7.58M 5.54M 3.73M 3.21M 2.99M 2.79M 2.77M 2.24M 2.44M 2.33M 1.4M
Stock-Based Compensation
26.16M 36.06M 30.78M 18.25M 16.52M 16.13M 16.09M 16.79M 11.81M 8.81M 7.7M 8.91M 5.67M 5.63M 4.34M 3.36M 5.32M 1.82M
Other Working Capital
n/a -14.38M -2.07M 47.92M -9.66M -36.58M -4.53M -6.65M -7.6M -24.07M -1.3M -8.48M -8.55M 121.48M -452K -2.5M -2.5M -2.5M
Other Non-Cash Items
45.47M 15.14M 13.69M -35.55M 34.19M 32.8M 52.54M 170K 2.03M 3.87M 2.44M 1.77M 5.01M 2.14M 1.16M 464K 2.38M 101K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -54.06M 19K n/a n/a n/a n/a n/a n/a n/a 827K n/a n/a
Change in Working Capital
n/a n/a 6.05M 46.72M -10.26M -36.45M -11.27M -4.46M -10.12M -24.4M -601K -7.76M -9.54M 122.82M -3.96M 7.29M -275K -3.36M
Operating Cash Flow
-76.42M -131.96M -115.43M -59.23M -82.22M -102.3M -74.08M -72.92M -67.47M -73.32M -44.75M -54.54M -61.62M 77.39M -61.16M -33.05M -33.65M -30.75M
Capital Expenditures
-3.15M -1.83M -1.65M -1.56M -4.18M -6.65M -2.42M -827K -3.97M -5.34M -7.98M -8.56M -16.48M -4.34M -4.46M -9.71M -6.21M -19.42M
Cash Acquisitions
n/a n/a 277.1M n/a n/a n/a -71K n/a 1.92M n/a n/a n/a n/a n/a -184.17M n/a n/a n/a
Purchase of Investments
-500K 3.44M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -116.97M -184.17M n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a 480K n/a n/a n/a 61.55M 21.41M 147.65M 69.19M n/a n/a n/a
Other Investing Acitivies
-2.16M -8.88M -350K -3M -3M n/a -350K 398K n/a -165K -300K 61.25M 21.41M 147.65M 184.17M -184.17M n/a n/a
Investing Cash Flow
-5.81M -7.27M 275.46M -4.56M -4.18M -6.65M -2.49M -347K -2.05M -5.34M -7.98M 52.98M 4.94M 143.3M -52.24M -193.87M -6.21M -19.42M
Debt Repayment
n/a -2.05M -2.1M -2.29M -26K -26K -694K -24K -24K -24K -23K -23K -22K -22K -21K -12.74M -20K -20K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
99.74M 40.53M 1.71M 1.78M 1.6M 3.05M 3.26M 3.79M 3.81M 1.95M 3.57M 2.36M 2.69M 2.11M 3.82M 1.64M 463.73M 2.15M
Financial Cash Flow
97.66M 40.53M 10.64M 16.46M 263.12M 13.9M 80.66M 53.77M 3.79M 1.92M 147.26M 2.34M 2.67M 2.08M 3.8M -11.1M 463.7M 2.13M
Net Cash Flow
24.69M -93.87M 167.19M -40.29M 176.6M -95.28M 5.22M -19.62M -65.55M -76.74M 94.22M 780K -54.02M 222.78M -109.61M -238.02M 423.84M -48.04M
Free Cash Flow
-79.57M -133.79M -117.08M -60.79M -86.4M -108.95M -76.49M -73.75M -71.44M -78.66M -52.73M -63.1M -78.1M 73.05M -65.62M -42.75M -39.87M -50.17M